Cenrifki
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cenrifki, covering 2026-06-25 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Cenrifki (tolebrutinib) — Sanofi Winthrop Industrie